Phototherapy Market USD 389.5 Million in 2023

The global phototherapy market size was USD 389.5 Million in 2023 and is expected to register a revenue CAGR of 4.8% during the forecast period. Rising adoption of Light-emitting Diode (LED)-based phototherapy, increasing awareness of skin diseases, and launch of technologically advanced phototherapy equipment are driving the phototherapy market revenue growth.

Phototherapy also known as light therapy, is the use of Ultraviolet (UV) lights for its healing effects. Phototherapy is used across the globe to treat chronic skin conditions including eczema, vitiligo, and severe psoriasis. While many medical treatments compromise the immune system as a whole, UV radiation can compromise the local immune system of the skin. In conditions such as psoriasis, phototherapy therapy can also postpone the development of thick, scaly skin. Increased capacity to activate melanocytes, pigment-producing cells of the skin, phototherapy therapy is utilized to treat vitiligo. This makes phototherapy the best treatment choice for everybody especially people who dislike creams, want a natural treatment, a treatment without steroids, and want more control utilizing a mix of therapies.

Request a Sample@ https://www.qyresearchmedical.com/sample/119198

Phototherapy has a significant impact on the management of many different skin conditions and is a very successful therapeutic treatment technique in dermatology. Non-ionizing radiation from the UV region of the electromagnetic spectrum is carefully administered to the skin in order to treat different dermatoses. This radiation typically includes the Utraviolet A (UVA) spectrum, Ultraviolet A-1 (UVA-1), UVA spectrum with a Psoralen sensitizer (PUVA), and Ultraviolet B (UVB) spectrum, also known as broadband (BB)-UVB or Narrowband Ultraviolet B phototherapy (NB)-UVB. For instance, on 22 August 2022, Korea-based Sewon NC announced that it will commercialize Organic Light‐emitting Diode (OLED)-based phototherapy solutions to treat pain and various skin conditions. The KAIST-developed OLED optical patch is a flexible platform that can be fastened to the body. It is less than 1 mm thick and relies on flexible OLED screens. Preclinical experiments using the patches were conducted in the first half of 2022, and they produced good results. Sewon intends to broaden the use of the patches in further areas, including the treatment of skin conditions, including wrinkles, skin cancer, dementia, and other skin disorders.

Market Dynamics:

Driver:  Rising adoption of LED-based phototherapy

One of the key factors driving revenue growth of the global phototherapy market share is rising popularity of the adoption of LED-based treatments. A physical or mental ailment can be treated using phototherapy, which uses light radiation. Cells and tissues might respond differently depending on the wavelength and therapeutic dosage of the illumination. Increase in collagen levels in the skin, which can lessen the appearance of wrinkles and other signs of aging, is one of the key advantages of LED-based phototherapy. Other uses of LED light therapy include acne, dermatitis, eczema, psoriasis, rosacea, scarring, and sun damage. LED light therapy has an antimicrobial effect, making it effective at killing several types of bacteria that can collect pores and oil glands and cause breakouts. In a study, people with acne who were treated for five weeks with LED phototherapy saw an improvement in 77% of cases. Major companies are launching new and advanced technologies, which will further drive revenue growth of LED-based phototherapy. For instance, Elipsa, the newest LED light treatment invention from LightStim, which seamlessly interacts with BeautyHealth’s next-generation HydraFacial system, Syndeo, is poised for exponential growth in 2022. The new LightStim Elipsa improves treatment outcomes and the provider experience. Elipsa is now accessible in the U.S. for retail and business usage, and it will eventually go worldwide in partnership with Syndeo, expanding LightStim’s reach on a national and international scale.

Restraint:  Side effects and risks associated with phototherapy treatment

Phototherapy includes risks such as UV rays, which can damage the skin cells. They can hasten the appearance and feel of aging on the skin. The term ‘photoaging’ is another name for this early aging of the skin. In several earlier investigations, it was discovered that prolonged exposure to artificial UV radiation increased the chance of developing skin cancer. Recent research has revealed that PUVA can raise the risk of skin cancer, while narrowband UVB therapy does not. When the immune system is suppressed by light treatment, the body is more susceptible to illnesses, infections, and skin malignancies. Eyes can become more sensitive to light after receiving photodynamic therapy or PUVA treatments for cancer. If sensitive eyes are exposed to sunshine or other strong lights, it can result in cular injury. Cataracts can also form as a result of phototherapy. These factors could restrain revenue growth of the global phototherapy market.

Some Key Takeaways:

Device Type Outlook:

On the basis of device type, the global phototherapy market is segmented into Compact Fluorescent Light (CFL), LED, and lamps. The LED segment is expected to have the fastest revenue CAGR during the forecast period. The development in the use of LED for the therapy of neonatal jaundice in neonates has increased its demand throughout the years. Target illnesses are treated using LED-based phototherapy equipment since it employs the LED as a light source to accurately focus on the diseased region with the right wavelengths. LED-based devices cure the damaged region in a shorter amount of time compared to other devices. These benefits encourage people to choose LED-based phototherapy. Fine wrinkles, psoriasis, and acne are among the skin conditions and disorders that are treated using LED-based phototherapy. The adoption of LED-based phototherapy equipment is expected to increase as the number of persons with such skin problems rises. For instance, 85% of people at some time in their lives can develop acne, according to MDALGORITHMS INC. Furthermore, according to Pushups, LLC, almost 60% of Americans are uncomfortable with their own skin owing to wrinkles and other skin-related disorders. This might lead to rise in the adoption of phototherapy equipment with LEDs, and drive revenue growth of the market during the forecast period.

Application Outlook:

Based on application the global phototherapy market is segmented into skin diseases, mood and sleep disorders, cancers & pre-cancers, neonatal jaundice, and other diseases. The skin diseases segment accounted for largest revenue share in 2021 owing to rising prevalence of various skin diseases among people. Skin issues such as vitiligo and eczema are a couple of the frequent skin conditions that might help the particular market sector operate well. In the near future, increased use of the therapy is expected to support revenue growth of the segment.

The neonatal jaundice segment is expected to register fastest revenue CAGR during the forecast period owing to rising rates of newborn jaundice across the globe and growing number of infants. For instance, neonatal jaundice is notably common in the United Kingdom, where between 5 and 10% of infants delivered at term are treated with phototherapy. The number of births has also increased internationally. For instance, statistics show, in the first quarter of 2021, 13,700 infants were born in Norway, which is 700 higher than the first quarter in 2020, according to the country’s quarterly demographic statistics. Given the aforementioned considerations, the neonatal jaundice segment revenue growth is expected to increase at a high rate over the forecast period.

Therapy Type Outlook:

Based on therapy type, the global phototherapy market is segmented into Ultraviolet B (UVB), and Psoralen Ultraviolet A (PUVA). The UVB segment accounted for largest revenue share in 2021. UVB segment is further divided into broadband UVB and narrowband UVB. Broadband UVB uses a wide range of UVB rays. These are commonly present in sun rays and cannot be detected with open eyes. Narrowband UVB uses a smaller, more intense part of UVB to treat the skin condition. It is the most common type of light therapy used in recent times. Broadband UVB has been utilized historically, but narrowband UVB phototherapy (311 nm) is becoming more common. With each exposure, more UVB dosages are administered. The intensity and scope of the common genetic skin condition psoriasis can vary greatly. No treatment, including phototherapy, has a permanent curative effect. The majority of patients with severe psoriasis can benefit from UVB. It might not work for people with very pale skin or psoriasis that becomes worse in the sun.

The Psoralen UVA segment is expected to register fastest revenue CAGR during the forecast period. Psoralen ultraviolet A or PUVA is a combination of UVA light with a chemical called psoralen, which comes from plants. Psoralen can be applied to the skin or can be taken as a pill as well. Under the influence of UVA radiation, the psoralen molecule can integrate into the DNA of bacteria, viruses, and fungal organisms, harming them and stopping reproduction. As a result, they significantly amplify the impact of UVA light on the skin if they are present in the skin at the moment of exposure. The secret to favorable impact of PUVA therapy for skin problems is its heightened sensitivity. It is important to stress that psoralens do not influence skin or skin problems on their own. This therapy is efficient in treating a range of skin disorders when combined with UVA light.

End-use Outlook:

Based on end-use, the global phototherapy market is segmented into clinics, hospitals, dermatology centers, and homecare. Hospital segment accounted for the largest revenue share in 2021. This can be attributed to the given number of hospitals available across the globe. Sterilization is frequently used in hospitals, which aids in the treatment of skin diseases in patients. Hospitals have been using new digital technologies that boost therapeutic efficacy through high accuracy and better user safety. An updated study of NB-UVB was published in June 2022, and despite some patients being classified as nonresponders, it found that the therapy had good effectiveness and safety when used to treat non-segmental vitiligo. The research stated that systemic corticosteroids, topical calcineurin inhibitors, certain antioxidants, and combination therapy have all been found to increase the effectiveness of the treatment when used in addition to phototherapy alone. In additionally, on 9 September 2022, the U.S. Food and Drug Administration (FDA) approved deucravacitinib (Sotyktu, Bristol Myers Squibb) to treat adults with moderate to severe plaque psoriasis who are candidates for systemic therapy or phototherapy.

Regional Outlook:

Based on regional analysis, North America accounted for largest market revenue share in 2021. North America is expected to hold a significant market share majorly owing to substantial impact in determining the global market size for phototherapy. Strong demand for phototherapy products in the region for skin treatment is the key factor driving revenue growth of the market. In addition, technological developments, access to adequate infrastructure, and increase in newborn jaundice and skin problems in the region are supporting revenue growth of the market. According to the National Eczema Association, eczema is a skin disorder that affects about 31.6 million people in the U.S., which creates a high demand for phototherapy. Furthermore, one of the major factors driving revenue growth of the market in this region is use of innovative technology in the phototherapy procedure.

The market in Asia Pacific is expected to register a significant revenue CAGR during the forecast period. The rapid growth rate can be attributed to increase in preterm births and a rise in the number of persons with skin diseases. For instance, according to The Lancet, 80% of late preterm births take place in Asia and South Asia, accounting for around 85% of all preterm births. Furthermore, according to Narayan Health Organization, one-fifth of the 15 million preterm births that occur across the globe, occur in India alone, which further raises the instances of neonatal jaundice thereby increasing demand for phototherapies. In addition, acne is common in Asia Pacific, which is expected to increase demand for phototherapy equipment. For instance, the Derma Health Institute reports that acne is a widespread issue for persons of Asian ancestry, which is driving demand for phototherapy equipment in this region.

The market in Europe is expected to grow moderately over the forecast period owing to technologically advanced and various financial aids, which encourage people to opt for this treatment. In 2020, the market value of phototherapy in Germany was approximately USD 56 million, while the market value of phototherapy in France was USD 34 million. According to HospeTrack Hospital Intelligence for the U.K., one of the significant opportunities for medical equipment manufacturers is the creation and expansion of 40 major hospitals throughout England by 2032. There will likely be an additional eight projects added to the pipeline at this time. The government’s heightened interest in improving its healthcare system is expected to lead to the development of phototherapy treatments.

Competitive Landscape:

Competitive landscape of the global phototherapy market is moderately consolidated with few major companies operating on global and regional levels. Major companies are engaged in product development and strategic alliances to expand their respective product portfolios and gain a robust footprint in the global market. Some major companies in the market report include General Electric Company, Signify Holding, Natus Medical Incorporated, Phoenix Medical System (P) Ltd, Herbert Waldmann GmbH & Co. KG, Atom Medical Corp., The Daavlin Company, Little Sparrows Technologies, and nice Neotech Medical Systems Pvt. Ltd.

Some recent developments are as follows:

  • On 16 November 2021, U.S.-based technological company Little Sparrows Technologies’ bili-hut cleared FDA approval for home-based phototherapy treatment for newborn babies with jaundice, reducing healthcare costs and keeping newborns and their families together during treatment. The apparatus provides high-intensity phototherapy comparable to NICU-intensity therapies. Additionally, it is portable, foldable, lightweight, and energy-efficient enough to run on batteries. The bili-hut is perfect for usage in hospitals, at home, or in a variety of settings, including rural and resource-limited places, and is simply cleaned with typical hospital sanitizing chemicals.

Segments Covered in the report

This report offers historical data and forecasts revenue growth at a global, regional, and country level, and provides analysis of the market trends in each of the sub-segments from 2023 to 2032. For the purpose of this report has segmented the global Phototherapy market based on device type, application, therapy type, end-use, and region:

Phototherapy Market Report Scope

Segments covered By Device Type Outlook, Application Outlook, Therapy Type Outlook, End-use Outlook, Regional Outlook

By Device Type Outlook              

CFL

LED

Lamps

By Application Outlook

Skin Diseases

Mood and Sleep disorders

Cancers and Pre-cancers

Neonatal jaundice

Other Diseases

By Therapy Type Outlook            

Ultraviolet B

Broadband UVB

Narrowband UVB

Psoralen Ultraviolet A

By End-use Outlook       

Clinics

Hospitals

Dermatology Center

Homecare

Regional scope

North America

Europe

Asia Pacific

Latin America

Middle East & Africa

Buy quantitative research Report at discounted price – USD 1500 https://www.qyresearchmedical.com/report/checkout/119198/1500

You can place an order or ask any questions, please feel free to contact sales@qyresearchmedical.com | +1 9197 992 333

Blog: https://www.novaoneadvisor.com/

Blog: https://www.visionresearchreports.com/

About Us

QYResearch Medical has more than 4000 global well-known customers, covering more than 30 industries including pharmaceuticals, medical technology & devices, healthcare services etc. Company services cover one-stop solution as Data-Analysis-Suggestion-Consulting Implementation. Research regions cover North America, Europe, Latin America, Middle East and Africa, Asia- Pacific.

For Latest Update Follow Us:

URL – http://www.qyresearchmedical.com/

https://www.linkedin.com/company/qyresearch-medical/

https://www.facebook.com/QYResearch-Medical-108186514228917/

https://twitter.com/qyresearchmedi

Leave a Comment

Your email address will not be published. Required fields are marked *